Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4411241 | 0.76 | ALDH1A1 (0.39) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4407893 | 0.74 | CNR2 (0.32) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4409241 | 0.74 | CNR2 (0.32) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4413524 | 0.74 | ALDH1A1 (0.50) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4408301 | 0.74 | CNR2 (0.32) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4405716 | 0.72 | ALDH1A1 (0.42) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL4406055 | 0.72 | CNR2 (0.51) | CYP1A2TDP1CNR2ALDH1A1 | |
| SCHEMBL25005926 | 0.71 | — | — | |
| SCHEMBL4405753 | 0.71 | ALDH1A1 (0.49) | ALDH1A1 | |
| SCHEMBL4408120 | 0.69 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | CYP2B6, CBR3, CYP2A6 | CYP1A2 40/4885TDP1 4690/4885CNR2 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.